The global oral proteins and peptides market is on an upward trajectory, valued at USD 1.8 Billion in 2024 and anticipated to reach USD 3.4 Billion by 2033, growing at a CAGR of 7.13% (2025-2033), as reported by IMARC Group. North America, holding a commanding 97.8% market share in 2024, spearheads this growth due to advancements in non-invasive drug delivery methods and a rising need... https://www.imarcgroup.com/oral-proteins-peptides-market